Home » Topics » BioWorld Science

BioWorld Science
RSS

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Galderma discovers JAK-1 inhibitors

April 1, 2022

Medshine Discovery divulges thyroid hormone receptor beta agonists

April 1, 2022

BLU-945 for treatment-resistant EGFR T790M mutation-driven lung cancer

April 1, 2022

Zelluna collaborates with Etcembly and Nextera to optimize pipeline TCRs

March 31, 2022

Deleting protein switches macrophages to reduced-fat diet

March 31, 2022

New cathepsin L inhibitors for the treatment of HCC

March 31, 2022

Eloxx expands ELX-02 development program to include Alport syndrome

March 31, 2022

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

March 31, 2022

VYN-201 demonstrates promise in anti-collagen antibody-induced mouse model of RA

March 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...